Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Revenue (2019 - 2025)

Korro Bio (KRRO) has disclosed Revenue for 5 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue changed N/A year-over-year to $1.1 million, compared with a TTM value of $7.4 million through Sep 2025, changed N/A, and an annual FY2024 reading of $2.3 million, changed N/A over the prior year.
  • Revenue was $1.1 million for Q3 2025 at Korro Bio, down from $1.5 million in the prior quarter.
  • Across five years, Revenue topped out at $9.4 million in Q2 2021 and bottomed at -$284000.0 in Q1 2023.
  • Average Revenue over 4 years is $3.0 million, with a median of $2.3 million recorded in 2024.
  • Peak annual rise in Revenue hit 10.49% in 2021, while the deepest fall reached 35.97% in 2021.
  • Year by year, Revenue stood at $9.4 million in 2021, then crashed by 103.02% to -$284000.0 in 2023, then skyrocketed by 899.65% to $2.3 million in 2024, then tumbled by 52.0% to $1.1 million in 2025.
  • Business Quant data shows Revenue for KRRO at $1.1 million in Q3 2025, $1.5 million in Q2 2025, and $2.6 million in Q1 2025.